Acquiring Company
IDEXX Laboratories
Acquired Company
CoVetAI
Description
IDEXX Laboratories has acquired CoVetAI to improve veterinary workflow intelligence. This acquisition aims to integrate AI solutions into their services. The move is expected to enhance decision-making in veterinary practices.
Don't miss IDEXX Laboratories's next move
Get an email the moment IDEXX Laboratories makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired CoVetAI?
CoVetAI was acquired by IDEXX Laboratories, based in Westbrook. The deal was reported on September 16, 2026. IDEXX Laboratories, Inc. is a global leader in pet healthcare innovation, with a focus on enhancing the health and well-being of pets, people, and livestock. IDEXX Laboratories is publicly traded (IDXX) and operates in Health Care.
When did IDEXX Laboratories acquire CoVetAI?
IDEXX Laboratories's acquisition of CoVetAI was reported on September 16, 2026. IDEXX Laboratories has acquired CoVetAI to improve veterinary workflow intelligence. This acquisition aims to integrate AI solutions into their services. The move is expected to enhance decision-making in veterinary practices. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does CoVetAI do?
CoVetAI focuses on artificial intelligence solutions to streamline veterinary workflows. The company aims to improve decision-making processes in veterinary practices. Their technology enhances data analysis for better patient outcomes. It is privately held, operating in Information Technology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.